产品名称：L-α-磷脂酰甘油(鸡蛋)(钠盐)
英文名称：L-α-phosphatidylglycerol (Egg, Chicken) (sodium salt)
别名：磷脂酰甘油(鸡蛋)
英文别名：Egg PG
规格或纯度：≥99%
运输条件：超低温冰袋运输
生化机理
Phosphatidylglycerol (PG) is an indicator of fetal lung maturity. It is a precursor for cardiolipin in animals. In plants, PG is present in thylakoid membranes and plays a central role in photosynthesis
CAS编号：383907-64-0
敏感性
对空气敏感；对光敏感
储存温度
避光,-20°C储存,充氩
分子量：782.284
分子式：C40H76NaO10P
Phosphatidylglycerol (PG) is one of the major phospholipids in food and biological tissues. PG, structurally has two acyl chains esterified to a glycerol, which in turn is bonded to a headgroup structure that has phosphate and carries negative charge. PG is abundant in bacterial membranes and present in lower amounts in mammalian membranes. It is abundant in lung surfactant. PG is synthesized from cytidine phosphate-diacylglycerol (CDP-DAG).Egg PG has been used as anionic phospholipid substrate in serial protein misfolding cyclic amplification (sPMCA) reaction. It is also suitable for use in the preparation of large unilamellar vesicles (LUVs) and as a standard for liquid chromatography-mass spectrometric analysis (LC-MS).
Phosphatidylglycerol (PG) is one of the major phospholipids in food and biological tissues. PG, structurally has two acyl chains esterified to a glycerol, which in turn is bonded to a headgroup structure that has phosphate and carries negative charge. PG is abundant in bacterial membranes and present in lower amounts in mammalian membranes. It is abundant in lung surfactant. PG is synthesized from cytidine phosphate-diacylglycerol (CDP-DAG).Egg PG has been used as anionic phospholipid substrate in serial protein misfolding cyclic amplification (sPMCA) reaction. It is also suitable for use in the preparation of large unilamellar vesicles (LUVs) and as a standard for liquid chromatography-mass spectrometric analysis (LC-MS).
德尔塔生物的产品主要服务于药物靶标发现，先导化合物发现、合成及优化，药物候选化合物发现等新药研发的关键环节。以药物构效和构性关系、药物化合物逆合成分析等理论为指导，公司多年密切跟踪药物化合物的动态，形成以药物分子砌块研发设计、定制化合成、分子结构确证、纯度检测及纯化等为代表的核心技术体系，构筑起种类全、规模大的药物分子砌块产品库，能够满足客户对药物分子砌块的高技术、多品类、微小剂量及多频次需求。
德尔塔生物致力于成为全球药物分子砌块领域的领先企业，实现紧跟医药前沿研发方向，及时开发出结构独特、功能多样的药物分子的类型，快速响应客户对药物分子砌块和科学试剂的多样化需求，助力全球新药研发机构加速新药研发进程或降低新药研发成本。